Skip to content

Author

Kalpana Babu

We have 1 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Tofacitinib for Refractory Non-Infectious Ocular Inflammation: A Retrospective Observational Study.

Tofacitinib was associated with a significant reduction in ocular flares and improvement in visual outcomes in patients with refractory non-infectious ocular inflammation, suggesting that JAK inhibition may represent an effective and economically viable therapeutic option for selected patients with difficult-to-treat o...

Vidya S. Mooss, Kalpana Babu, Haridas Mundot Puliappadamb · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.